Acarix AS (Sweden) Top Management

ACARIX Stock  SEK 0.27  0.01  3.85%   
Acarix AS employs about 8 people. The company is managed by 6 executives with a total tenure of roughly 19 years, averaging almost 3.0 years of service per executive, having 1.33 employees per reported executive. Analysis of Acarix AS's management performance can provide insight into the company performance.
Christian Lindholm  Insider
Chief Officer
Marianne Norskov  Insider
Chief Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acarix AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Acarix AS Management Team Effectiveness

The company has return on total asset (ROA) of (0.7996) % which means that it has lost $0.7996 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.458) %, meaning that it generated substantial loss on money invested by shareholders. Acarix AS's management efficiency ratios could be used to measure how well Acarix AS manages its routine affairs as well as how well it operates its assets and liabilities.
Acarix AS holds a total of 373.33 Million outstanding shares. Acarix AS shows 10.28 percent of its outstanding shares held by insiders and 2.84 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Acarix AS in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Acarix AS, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Acarix AS Workforce Comparison

Acarix AS is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 451. Acarix AS claims roughly 8.0 in number of employees contributing just under 2% to equities under Health Care industry.

Acarix AS Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Acarix AS Price Series Summation is a cross summation of Acarix AS price series and its benchmark/peer.

Acarix AS Notable Stakeholders

An Acarix AS stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Acarix AS often face trade-offs trying to please all of them. Acarix AS's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Acarix AS's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
String symbol = request.getParameter("s");

About Acarix AS Management Performance

The success or failure of an entity such as Acarix AS often depends on how effective the management is. Acarix AS management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Acarix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Acarix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Acarix AB , a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Acarix AB was founded in 2004 and is based in Malm, Sweden. Acarix AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.
Please note, the presentation of Acarix AS's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acarix AS's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Acarix AS's management manipulating its earnings.

Acarix AS Workforce Analysis

Traditionally, organizations such as Acarix AS use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Acarix AS within its industry.

Acarix AS Manpower Efficiency

Return on Acarix AS Manpower

Revenue Per Employee470K
Revenue Per Executive626.7K
Net Loss Per Employee6.5M
Net Loss Per Executive8.6M

Complementary Tools for Acarix Stock analysis

When running Acarix AS's price analysis, check to measure Acarix AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acarix AS is operating at the current time. Most of Acarix AS's value examination focuses on studying past and present price action to predict the probability of Acarix AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acarix AS's price. Additionally, you may evaluate how the addition of Acarix AS to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements